Sicova M, Guest NS, Tyrrell PN, El-Sohemy A. Caffeine, genetic variation and anaerobic performance in male athletes: a randomized controlled trial.
Eur J Appl Physiol 2021;
121:3499-3513. [PMID:
34529114 DOI:
10.1007/s00421-021-04799-x]
[Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2021] [Accepted: 08/18/2021] [Indexed: 11/26/2022]
Abstract
PURPOSE
The effect of caffeine on anaerobic performance is unclear and may differ depending on an individual's genetics. The goal of this study was to determine whether caffeine influences anaerobic performance in a 30 s Wingate test, and if 14 single nucleotide polymorphisms (SNPs) in nine genes, associated with caffeine metabolism or response, modify caffeine's effects.
METHODS
Competitive male athletes (N = 100; 25 ± 4 years) completed the Wingate under three conditions: 0, 2, or 4 mg of caffeine per kg of body mass (mg kg-1), using a double-blinded, placebo-controlled design. Using saliva samples, participants were genotyped for the 14 SNPs. The outcomes were peak power (Watts [W]), average power (Watts [W]), and fatigue index (%).
RESULTS
There was no main effect of caffeine on Wingate outcomes. One significant caffeine-gene interaction was observed for CYP1A2 (rs762551, p = 0.004) on average power. However, post hoc analysis showed no difference in caffeine's effects within CYP1A2 genotypes for average power performance. No significant caffeine-gene interactions were observed for the remaining SNPs on peak power, average power and fatigue index.
CONCLUSION
Caffeine had no effect on anaerobic performance and variations in several genes did not modify any effects of caffeine.
TRIAL REGISTRATION
This study was registered with clinicaltrials.gov (NCT02109783).
Collapse